The patient with the 65% tumour reduction – is that a good result? Would you have expected to see that sort of response in this patient if treated with doxorubicin?
Listen to the answer if you have any doubts as to what the platform is delivering.
The rerate is not up to the company though. As you say they have already said the pre|CISION platform works. They aren't boosters but they do have something to shout from the hill tops about.
Just takes more buy in to the tech that clearly works. Which is what employing the latest signing is all about.